- Home
- LADR vs CNTA Comparison
LADR vs CNTA Comparison
Compare LADR & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LADR
- CNTA
- Stock Information
- Founded
- LADR 2008
- CNTA 2020
- Country
- LADR United States
- CNTA United Kingdom
- Employees
- LADR N/A
- CNTA 86
- Industry
- LADR Real Estate Investment Trusts
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- LADR Real Estate
- CNTA Health Care
- Exchange
- LADR Nasdaq
- CNTA Nasdaq
- Market Cap
- LADR 1.5B
- CNTA 1.6B
- IPO Year
- LADR 2014
- CNTA 2021
- Fundamental
- Price
- LADR $10.58
- CNTA $12.43
- Analyst Decision
- LADR Buy
- CNTA Strong Buy
- Analyst Count
- LADR 6
- CNTA 11
- Target Price
- LADR $13.17
- CNTA $27.00
- AVG Volume (30 Days)
- LADR 619.3K
- CNTA 1.2M
- Earning Date
- LADR 07-24-2025
- CNTA 08-12-2025
- Dividend Yield
- LADR 8.70%
- CNTA N/A
- EPS Growth
- LADR 7.86
- CNTA N/A
- EPS
- LADR 0.82
- CNTA N/A
- Revenue
- LADR $259,161,000.00
- CNTA $15,000,000.00
- Revenue This Year
- LADR N/A
- CNTA N/A
- Revenue Next Year
- LADR $16.49
- CNTA N/A
- P/E Ratio
- LADR $12.91
- CNTA N/A
- Revenue Growth
- LADR 1.39
- CNTA 118.88
- 52 Week Low
- LADR $9.68
- CNTA $8.46
- 52 Week High
- LADR $12.48
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- LADR 50.15
- CNTA 47.36
- Support Level
- LADR $10.47
- CNTA $11.77
- Resistance Level
- LADR $10.69
- CNTA $13.06
- Average True Range (ATR)
- LADR 0.16
- CNTA 0.70
- MACD
- LADR -0.00
- CNTA 0.03
- Stochastic Oscillator
- LADR 46.49
- CNTA 51.21
About LADR Ladder Capital Corp
Ladder Capital Corp is an internally-managed real estate investment trust that is in commercial real estate finance. The company originates and invests in a diverse portfolio of commercial real estate and real estate-related assets, focusing on senior secured assets. The company's investment activities include: (i) Primary business of originating senior first mortgage fixed and floating rate loans collateralized by commercial real estate with flexible loan structures; (ii) owning and operating commercial real estate, including net leased commercial properties; and (iii) investing in investment-grade securities secured by first mortgage loans on commercial real estate. The company has three reportable segments include loans: which derives maximum profit; securities; and real estate.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.